Skip to content
Recall Observatory FDA recall evidence

Drug product

Gabapentin Tablets, USP, 600 mg, 500-count bottles, Rx only, Manufactured by: Granules India Limited Hyderabad-500 081, India, Manufactured for: Granules Pharmaceuticals Inc., Chantilly, VA NDC 70010-227-05

D-0634-2024

July 31, 2024

Class II

Product summary

Firm
Granules Pharmaceuticals Inc.
Event
Event 95072
Status
Terminated
Classification
Class II
Quantity
11,808 500-count Bottles
Official record key
drug-enforcement:D-0634-2024

Official wording

Reason: Presence of Foreign Tablets; 3 fused tablets of Metformin ER 500 mg were found in bottle of Gabapentin Tablets

Code information: Lot 1380040A, Exp. date July 31, 2025

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    Foreign Tablets